You are here

Lantheus Holdings

Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront

Medical Marketing and Media

Wed, 01/29/25 - 11:24 am

Lantheus Holdings

radiopharmaceuticals

Evergreen Theragnostics

Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street

BioSpace

Mon, 12/18/23 - 10:14 pm

Point Biopharma

Lantheus Holdings

prostate cancer

Big caps bounce back for biopharma

EP Vantage

Mon, 01/16/23 - 11:14 am

Bristol Myers Squibb

Gilead Sciences

Lantheus Holdings

Madrigal Pharmaceuticals

Moderna Therapeutics

Prometheus Biosciences